Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 1/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 2/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27514525 | 0.96 | GRIK1 (0.35) | GRIK1GRIK2FAAHBACE1ALDH1A1 | |
| SCHEMBL93436 | 0.96 | GRIK1 (0.35) | GRIK1GRIK2FAAHBACE1ALDH1A1 | |
| Sulfuric Acid SCHEMBL9324956 | 0.89 | GRIK1 (0.32) | GRIK1GRIK2 | |
| SCHEMBL2500222 | 0.84 | ALDH1A1 (0.39) | GRIK1FAAHALDH1A1 | |
| SCHEMBL28735647 | 0.84 | ALDH1A1 (0.39) | GRIK1FAAHALDH1A1 | |
| SCHEMBL4543916 | 0.84 | — | — | |
| Chloromethane SCHEMBL6934346 | 0.83 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL15281927 | 0.81 | EP300 (0.48) | FAAH | |
| SCHEMBL407636 | 0.79 | GRIK1 (0.31) | GRIK1GRIK2FAAHALDH1A1 | |
| SCHEMBL4899847 | 0.79 | GRIK1 (0.31) | GRIK1GRIK2FAAHALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230263936-A1 | CELL OR TISSUE EMBEDDING DEVICE | NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) | 2023-08-24 | — | — | US | disclosed |
| US-11684693-B2 | Cell or tissue embedding device | JAPAN VAM & POVAL CO., LTD. (JP) | 2023-06-27 | — | — | US | disclosed |
| EP-4015477-A1 | RESIN COMPOSITION, METHOD FOR MANUFACTURING RESIN COMPOSITION, OPTICAL FIBER, AND METHOD FOR MANUFACTURING OPTICAL FIBER | Sumitomo Electric Industries, Ltd. (JP) | 2022-06-22 | — | — | EP | disclosed |
| EP-3059266-B1 | METHOD OF PRODUCING POLYVINYL ALCOHOL RESIN, AND POLYVINYL ALCOHOL RESIN OBTAINED THEREBY | JAPAN VAM & POVAL CO LTD (JP) | 2020-10-21 | — | — | EP | disclosed |
| US-20200231960-A1 | CELL OR TISSUE EMBEDDING DEVICE | NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) | 2020-07-23 | — | — | US | disclosed |
| EP-2786745-B1 | AQUEOUS COSMETIC PREPARATION FOR SKIN | SHISEIDO CO LTD (JP) | 2019-03-13 | — | — | EP | disclosed |
| US-9707170-B2 | Water-based skin cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20160271988-A1 | METHOD FOR PRODUCING POLYVINYL ALCOHOL RESIN, AND POLYVINYL ALCOHOL RESIN OBTAINED BY THE METHOD | JAPAN VAM & POVAL CO., LTD. (JP) | 2016-09-22 | — | — | US | disclosed |
| EP-3059266-A1 | METHOD OF PRODUCING POLYVINYL ALCOHOL RESIN, AND POLYVINYL ALCOHOL RESIN OBTAINED THEREBY | Japan Vam & Poval Co., Ltd. (JP) | 2016-08-24 | — | — | EP | disclosed |
| WO-2016066633-A1 | NEW FILTRATION PROCESSES | BASF SE (DE) | 2016-05-06 | — | — | WO | disclosed |
| US-7927615-B2 | Thickener, cosmetic preparation containing the same, and process for producing the same | SHISEIDO COMPANY, LTD. (JP) | 2011-04-19 | — | — | US | disclosed |
| US-20100029787-A1 | Thickener, Cosmetic Preparation Containing The Same, And Process For Producing The Same | SHISEIDO COMPANY, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20090325101-A1 | Method for Producing Toner | BROTHER KOGYO KABUSHIKI KAISHA (JP) | 2009-12-31 | — | — | US | disclosed |
| EP-1803750-B1 | USE OF A POLYMER FOR SURFACE-TREATING A POWDER | SHISEIDO CO LTD (JP) | 2009-12-09 | — | — | EP | disclosed |
| EP-2112179-A1 | Surface-treated powders, and cosmetics comprising the same | Shiseido Co., Ltd. (JP) | 2009-10-28 | — | — | EP | disclosed |
| US-20080081029-A1 | acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability | SHISEIDO CO., LTD. (JP) | 2008-04-03 | — | — | US | disclosed |
| EP-1803750-A1 | SURFACE-TREATING AGENT, SURFACE-TREATED POWDER, AND COSMETIC PREPARATION CONTAINING SAME | Shiseido Company, Limited (JP) | 2007-07-04 | — | — | EP | disclosed |
| US-20050175564-A1 | Tickener, cosmetic preparation containing the same, and process for producing the same | SHISEIDO COMPANY, LTD. (JP) | 2005-08-11 | — | — | US | disclosed |
| EP-1505139-A1 | THICKENER, COSMETIC PREPARATION CONTAINING THE SAME, AND PROCESS FOR PRODUCING THE SAME | SHISEIDO COMPANY, LTD. (JP) | 2005-02-09 | — | — | EP | disclosed |
| EP-0484068-A2 | Thermoplastic resin composition | Suetsugu, Masao (JP) | 1992-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081029-A1 | acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability | CHRM1, H1-0, H1-2 | GRIK1 1461/4885GRIK2 2474/4885FAAH 1357/4885 |
| US-20050175564-A1 | Tickener, cosmetic preparation containing the same, and process for producing the same | TRHDE, FN1, SAMM50 | GRIK1 2560/4885GRIK2 2738/4885FAAH 527/4885 |
| US-20100029787-A1 | Thickener, Cosmetic Preparation Containing The Same, And Process For Producing The Same | POLD1, FASN, PCNA | GRIK1 3457/4885GRIK2 3621/4885FAAH 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.